Novartis is uniquely diversified across therapy areas with exposure to cutting-edge technology platforms. We have arguably the richest and broadest pipeline in the industry with more than 65 New Molecular Entities in development.
Please select your therapy area of interest to connect to one of our specialist, partnering professionals.
Novartis Pharmaceuticals and Novartis Oncology research, develop and commercialize Innovative Medicines to enhance health outcomes for patients and HCPs.
Our Sandoz Division is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
We are participating at #JPM2023– we look forward to seeing you there!
Get to know who is leading partnering at Novartis.
Share the journey with Novartis.
